Menopause and skin: what actually changes, and what helps

There is a particular consultation I have learned to listen for. A woman in her late forties or fifties says her skin changed, and she does not mean gradually. She means she noticed it over a season. It got drier, it stopped bouncing back, foundation started sitting in places it never used to, and a face that had always looked a certain way suddenly did not.

She is usually slightly apologetic about it, as though she is describing something vague. She is not. She is describing one of the better documented changes in skin biology, and almost nobody has explained it to her.

What estrogen was doing

Estrogen is not a background player in skin. It stimulates collagen synthesis, supports dermal elasticity and drives water retention.¹ It significantly increases levels of glycosaminoglycans and hyaluronic acid in the dermis, which is what gives skin its water-holding capacity and supports barrier function.² It also enhances the migration of dermal fibroblasts and promotes collagen deposition, which is why wound healing changes too.²

So when estrogen falls, it is not one system that shifts. It is structure, hydration, barrier and repair, all at once, which is exactly why the change registers as a whole-face event rather than a specific complaint.

What the numbers look like

Women lose approximately 30 percent of cutaneous collagen in the first five years after menopause.² For context, the gradual decline that runs through adult life is nothing like that steep.

The more interesting finding is the one underneath it. That loss is more closely correlated with the duration of estrogen deficiency than with chronological age.²

Sit with that, because it reframes the whole thing. Two women the same age can have meaningfully different skin depending on when their menopause occurred. Someone who went through it early has been accumulating that deficit for longer. The relevant clock is not how old you are. It is how long you have been without estrogen.

Alongside the collagen loss come the things patients actually report: dryness and a barrier that no longer holds water the way it did, loss of elasticity, increased wrinkling, and slower healing after any injury or procedure. Postmenopausal women show delayed re-epithelialisation and reduced collagen deposition compared with premenopausal controls.² That last one has practical consequences for how aggressively anyone should be treated.

Two more that surprise people. Acne affects roughly 25 percent of perimenopausal women, driven by a shifting balance between falling estrogen and relatively unopposed androgens.² And hirsutism affects up to 50 percent of postmenopausal women.² Breaking out at 52 is not a sign you are doing something wrong.

What hormone therapy does for skin

This is where I want to be careful, and where being an internist rather than only an aesthetics practitioner changes how I answer.

The skin effects are real and measurable. One trial demonstrated a 30 percent increase in dermal thickness after a year of oral estrogen therapy; another found a 6.49 percent increase in skin collagen after six months.² Estrogen deficiency produces increased wrinkling and reduced elasticity, and both improve demonstrably with hormone replacement.²

And yet the same review is direct about the limits: the role of hormone therapy as a primary or adjunctive treatment for dermatological conditions requires more robust evaluation.²

So here is my honest position. Menopausal hormone therapy is a whole-person decision made on the basis of symptoms, cardiovascular and bone health, personal and family history, and individual risk. It is not a skin decision, and it should not be marketed as one. If you are considering it, the skin benefit is a genuine bonus rather than an indication, and that conversation belongs with the clinician managing your menopause. What I can do is make sure nobody tells you the skin changes are imaginary.

One specific caution worth naming: topical estrogen has been associated with the development of melasma.² For patients with deeper skin, who are already at higher risk of pigmentary problems, that belongs in the conversation before anything is started. Melasma is difficult enough to treat without provoking it.

What works without hormones

Most of what helps here is available to everyone, and it is unglamorous.

Topical retinoids stimulate fibroblast-mediated collagen synthesis, improve elasticity and promote angiogenesis.² This is the single most useful topical in this setting, and it addresses the perimenopausal acne at the same time. Introduce it slowly, because skin that is already drier and healing more slowly is less forgiving than it used to be.

Rigorous photoprotection. Collagen you are trying to preserve is being degraded by ultraviolet exposure in parallel, and there is trial evidence that daily sunscreen slows photoaging measurably.

Barrier repair, treated as a real intervention. Gentle non-foaming cleansers, no stripping, and moisturizers that actually occlude. Much of what patients describe as their skin looking worse is barrier dysfunction rather than structural loss, and it is the fastest thing on this list to improve.

Targeted prescriptions where indicated. Topical retinoids and azelaic acid for acne, with antiandrogens such as spironolactone where appropriate. Minoxidil and other options for hair thinning. These are medical decisions, not product recommendations.

In-clinic collagen stimulation. Radiofrequency and biostimulators address the structural side, and are more relevant than resurfacing for most patients in this window, because the complaint is usually laxity rather than texture. Slower healing is a real reason to be more conservative with settings and to space treatments further apart than you might for a premenopausal patient.

What to be skeptical of

This is a market with a lot of money in it and not much evidence. The clinical literature is blunt about the lack of high-quality data behind many marketed products in this space, including oral supplements, phytoestrogens, LED therapies and probiotics.²

None of those are necessarily useless. They are simply not established, and they are frequently sold to women at exactly the moment they feel most urgent about it. If something is being marketed specifically for menopausal skin at a premium, the useful question is what would happen if you spent the same money on a prescription retinoid and a good sunscreen.

What to expect

The honest framing is that this is a change in the underlying conditions rather than a problem to be solved once. Skin during and after menopause needs a different routine than it needed at 35, and treatment plans should be built for slower healing and a more fragile barrier.

Improvement is available, and it is real. What is not available is a return to premenopausal skin, and I would rather say so at the first visit than let someone spend a year discovering it.